Indian lone commercial antivenom against Indian red scorpion venom demonstrates limited immunorecognition and partial neutralisation of enzymatic, pharmacological, and some toxic effects of Heterometrus bengalensis (Indian black scorpion) venom proteins in vitro and in vivo
Indian lone commercial antivenom against Indian red scorpion venom demonstrates limited immunorecognition and partial neutralisation of enzymatic, pharmacological, and some toxic effects of Heterometrus bengalensis (Indian black scorpion) venom proteins in vitro and in vivo
Indian lone commercial antivenom against Indian red scorpion venom demonstrates limited immunorecognition and partial neutralisation of enzymatic, pharmacological, and some toxic effects of Heterometrus bengalensis (Indian black scorpion) venom proteins in vitro and in vivo Abstract Scorpion envenomation remains a significant yet under-addressed public health issue in India. Heterometrus bengalensis (HB), a medically important scorpion, can induce clinically relevant local and systemic toxicity. However, limited research has evaluated the immunological recognition and neutralisation efficacy of existing commercial anti-scorpion antivenoms (ASV) against HB venom (HBV). This study evaluated the immunological cross-reactivity and neutralisation potential of a commercial ASV against HBV using in vitro and in vivo approaches. Immunochemical assays (enzyme-linked immunosorbent assay and Western blotting) demonstrated partial immunoreactivity toward H...
- Get link
- X
- Other Apps
